期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血清与脑脊液蛋白因子水平与精神分裂症临床症状的关系 被引量：4

下载PDF
导出
摘要 对血清蛋白因子水平与精神分裂症临床症状关系的研究综述如下。
作者 牛莉莉 熊鹏 曾勇 温科奇 李明 黄晓江
机构地区 昆明医科大学第一附属医院
出处 《临床精神医学杂志》 2014年第2期134-136,共3页 Journal of Clinical Psychiatry
基金 云南省社会发展科技计划项目(2011CA018) 云南省应用基础研究计划项目(2011FB172)
关键词 蛋白因子 精神分裂症 临床症状
分类号 R749.4 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献25

  • 1Zhang Y, Barres BA. Astrocyte heterogeneity: anunderappreciated topic in neurobiology[ J]. Curt Opin Neurobio,2010 ,20 :588-594.
  • 2Kronfol Z, Remick DG. Cytokines and the brain: implications for clinical psychiatry[ J]. Am J Psychiatry,2000,157:683-694.
  • 3He Y, Ya Z, Giegling I, et al. Schizophrenia shows a unique metabolomics signature in plasma[ J]. Transl Psychiatry,2012,2 : 149.
  • 4Wong J, Hyde TM, Cassano HL, et al. Promoter specific altera- tions of BDNF mRNA in schizophrenia[ J ]. Neurnscience, 2010, 169 : 1071-1084.
  • 5Yu H ,Zhang Z, Shi Y ,et al. Association study of the decreased se- rum BDNF concentrations in amnestic mild cognitive impairment and the Val66Met polymorphism in Chinese Han [ J ]. J Clin Psy- chiatry ,2008,69 : 1104-1111.
  • 6Chen DC, Wang J, Wang B, et al. Decreased levels of serum brain- derived neurotrophic factor in drug-naive first-episode schizophre- nia: relationship to clinical phenotypes [ J ]. Psychopharmacology, 2009,207 : 375-380.
  • 7Cowansage KK, LeDoux JE, Monfils MH. Brain-derived neurotro-phic factor: a dynamic gatekeeper of neural plasticity[ J]. Curr Mol Pharmacol,2010,3 : 12-29.
  • 8Krishnan V, Hart MH, Graham DL, et al. Molecular adaptations un- derlying susceptibility and resistance to social defeat in brain re- ward regions [ J ]. Cell,2007,131 : 391-404.
  • 9Rizos EN, Rontos ILaskos E, Arsenis G, et al. Investigation of ser- um BDNF levels in drug-naive patients with schizophrenia [ J ]. Progress Neuro-Psychopharmacology & Biological Psychiatry, 2008,32:1308-1311.
  • 10Chert SL, Lee SY, Chang YH,et al. Inflammation in patients with schizophrenia:the therapeutic benefits of risperidone plus add-on dextromethorphan[ J ]. J Neuroimmune Pharmacol, 2012,7 : 656- 664.

二级参考文献10

  • 1Van Kammen DP,McAllister-Sistilli CG,Kelley ME,et al.Elevated interleukin-6 in schizophrenia.Psychiatry Res,1999,87 (2-3):129.
  • 2Muller N,Riedel M,Ackenheil M,et al.The role of immune function in schizophrenia:an overview.Eur Arch Psychiatry Clin Neurosci,1999,249(S4):62.
  • 3Licinio J,Seibyl JP,Altemus M,et al.Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients.Am J Psychiatry,1993,150(9):1408.
  • 4Barak V,Barak Y,Levine J,et al.Changes in interleukin-1 beta and soluble interleukin-2 receptor levels in CSF and serum of schizophrenic patients.J Basic Clin Physiol Pharmacol,1995,6 (1):61.
  • 5El-Mallakh RS,Suddath RL,Wyatt RJ.Interleukin-1 alpha and interleukin-2 in cerebrospinal fluid of schizophrenic subjects.Prog Neuropsychopharmacol Biol Psychiatry,1993,17 (3):383.
  • 6Paterson GJ,Ohashi Y,Reynolds GP,et al.Selective increases in the cytokine,TNF {alpha},in the prefrontal cortex of PCP-treated rats and human schizophrenic subjects:influence of antipsychotic drugs.J Psychopharmacol,2006,20(5):636.
  • 7朱海兵,广州市精神病医院,郭扬波,广州市精神病医院,马崔,广州市精神病医院.白细胞介素-2与精神分裂症研究进展[J].国外医学（精神病学分册）,2000,27(3):189-192. 被引量：17
  • 8朱海兵,侯静,殷青云,胡号应,马崔,郭扬波.精神分裂症血清白细胞介素-2测定及其临床意义[J].中国神经精神疾病杂志,2002,28(3):221-222. 被引量：3
  • 9朱海兵,马崔,侯静,殷青云,胡号应,郭扬波.精神分裂症患者治疗前后血清白介素-6和α-干扰素的研究[J].中国神经精神疾病杂志,2002,28(5):324-326. 被引量：5
  • 10卢山,刘刚,孔祥泉,陈胜洪,陈继军,)姚咏明.首发精神分裂症患者中枢细胞因子的实验室研究[J].中国心理卫生杂志,2003,17(3):206-206. 被引量：4

共引文献7

同被引文献34

  • 1宋学勤,赵靖平,吕路线,李文强.首发精神分裂症患者IL-1β的血清蛋白水平及PBMC mRNA表达[J].临床心身疾病杂志,2006,12(5):321-323. 被引量：1
  • 2温科奇,熊鹏,曾勇,等.血清蛋白因子对精神分裂症疗效的评估和预测价值[J].中华临床医师杂志,2013,(20):9293.
  • 3Kreinin A, Lissort S, Nesher E. Blood BDNF level is gender specific in severe depression EJ~. PLoS One, 2015,26 (5):1371.
  • 4Huang TL, Lin CC. Advances in biomarkers of major depressive disorder EJ~. Adv Clin Chem, 2015,68 : 177.
  • 5Akyol ES, Albayrak Y, Beyazytiz M. Decreased serum levels of brain-derived neurotrophie factor in schizophrenic patients with deficit syndrome [J~. Neuropsychiatr Dis Treat,2015,30(11) :865.
  • 6Agilli M,Aydin FN. Serum brain derived neurotrophic factor evaluation in patients with chronic schizophrenia [J]. Psyehoneuroendocrinology, 2015,55 : 144.
  • 7Luo X, Huang L, Jia P, et al. Protein-protein interac- tion and pathway analyses of top schizophrenia genes reveal schizophrenia susceptibility genes converge on common molec- ular networks and enrichment of nucleosome (chromatin) as- sembly genes in schizophrenia susceptibility loci ~-J~. Schizo- phr Bu11,2014,40(1) :39.
  • 8Ajami A, Hosseini SH,Taghipour M. Changes in serum levels of brain derived neurotrophic factor and nerve growth factor-beta in schizophrenic patients before and after treatment [J]. Scand J Immunol,2014,80(1) :36.
  • 9Martinotti G, Di Iorio G, Marini S. Nerve growth factor and brain-derived neurotrophic factor concentrations in schizo- phrenia: a review [J]. J Biol Regul Homeost Agents,2012,26 (3) :347.
  • 10Steiner J, Westphal S, Schroeter M L, et al. Increased S100B+ NK cell counts in acutely ill schizophrenia patients are correlated with the free cortisol index, but not with S100B serum levels I-J]. Brain, Behavior, Immunity,2012,26(4) :564.

引证文献4

二级引证文献11

临床精神医学杂志
2014年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部